Advanced Enzyme [ADVENZYMES] vs Rossari Biotech [ROSSARI] Detailed Stock Comparison

Advanced Enzyme

NSE
Loading...

Rossari Biotech

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Advanced Enzyme wins in 8 metrics, Rossari Biotech wins in 12 metrics, with 0 ties. Rossari Biotech appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAdvanced EnzymeRossari BiotechBetter
P/E Ratio (TTM)27.1925.34Rossari Biotech
Price-to-Book Ratio2.612.89Advanced Enzyme
Debt-to-Equity Ratio2.6818.39Advanced Enzyme
PEG Ratio1.59-6.41Rossari Biotech
EV/EBITDA17.0114.11Rossari Biotech
Profit Margin (TTM)20.48%6.33%Advanced Enzyme
Operating Margin (TTM)25.18%9.22%Advanced Enzyme
EBITDA Margin (TTM)25.18%9.22%Advanced Enzyme
Return on Equity8.93%11.50%Rossari Biotech
Return on Assets (TTM)8.09%7.19%Advanced Enzyme
Free Cash Flow (TTM)$1.08B$-210.69MAdvanced Enzyme
Dividend Yield1.56%6.54%Rossari Biotech
1-Year Return-32.76%-26.45%Rossari Biotech
Price-to-Sales Ratio (TTM)5.561.60Rossari Biotech
Enterprise Value$32.05B$35.24BRossari Biotech
EV/Revenue Ratio4.801.65Rossari Biotech
Gross Profit Margin (TTM)73.08%31.70%Advanced Enzyme
Revenue per Share (TTM)$60$386Rossari Biotech
Earnings per Share (Diluted)$12.21$24.40Rossari Biotech
Beta (Stock Volatility)0.370.26Rossari Biotech
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Advanced Enzyme vs Rossari Biotech Stock Performance Analysis

Loading Price Chart...

Advanced Enzyme
Rossari Biotech
Advanced Enzyme Stock Overview | Rossari Biotech Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Advanced Enzyme-0.24%3.38%-2.43%-2.12%12.15%-5.66%
Rossari Biotech1.36%2.28%1.54%-5.23%3.02%-18.73%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Advanced Enzyme-32.76%17.43%-7.98%16.16%16.16%16.16%
Rossari Biotech-26.45%-30.94%-15.72%-11.82%-11.82%-11.82%

News Based Sentiment: Advanced Enzyme vs Rossari Biotech

Advanced Enzyme

News based Sentiment: POSITIVE

The company reported strong financial results in Q3 FY24 with double-digit growth in revenue and profit, and announced a share buyback, signaling confidence in future performance. These developments collectively strengthen the investment case and suggest a positive outlook.

View Advanced Enzyme News Sentiment Analysis

Rossari Biotech

News based Sentiment: MIXED

September was a month of conflicting signals for Rossari Biotech. While the company is actively pursuing international expansion and maintaining regulatory compliance, it faces bearish technical trends, underperforming stock performance, and shifting investor sentiment. These mixed developments create a cautiously optimistic outlook for investors.

View Rossari Biotech News Sentiment Analysis

Performance & Financial Health Analysis: Advanced Enzyme vs Rossari Biotech

MetricADVENZYMESROSSARI
Market Information
Market Cap i₹37.82B₹34.38B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i172,31477,738
90 Day Avg. Volume i872,28255,618
Last Close₹330.80₹644.80
52 Week Range₹257.90 - ₹520.70₹569.00 - ₹911.60
% from 52W High-36.47%-29.27%
All-Time High₹571.00 (Sep 16, 2024)₹1,619.00 (Oct 11, 2021)
% from All-Time High-42.07%-60.17%
Growth Metrics
Quarterly Revenue Growth0.20%0.11%
Quarterly Earnings Growth0.17%-0.04%
Financial Health
Profit Margin (TTM) i0.20%0.06%
Operating Margin (TTM) i0.25%0.09%
Return on Equity (TTM) i0.09%0.12%
Debt to Equity (MRQ) i2.6818.39
Cash & Liquidity
Book Value per Share (MRQ)₹127.00₹214.12
Cash per Share (MRQ)₹52.94₹21.20
Operating Cash Flow (TTM) i₹1.70B₹440.09M
Levered Free Cash Flow (TTM) i₹1.31B₹1.36B
Dividends
Last 12-Month Dividend Yield i1.56%6.54%
Last 12-Month Dividend i₹5.20₹43.78

Valuation & Enterprise Metrics Analysis: Advanced Enzyme vs Rossari Biotech

MetricADVENZYMESROSSARI
Price Ratios
P/E Ratio (TTM) i27.1925.34
Forward P/E i26.6718.44
PEG Ratio i1.59-6.41
Price to Sales (TTM) i5.561.60
Price to Book (MRQ) i2.612.89
Market Capitalization
Market Capitalization i₹37.82B₹34.38B
Enterprise Value i₹32.05B₹35.24B
Enterprise Value Metrics
Enterprise to Revenue i4.801.65
Enterprise to EBITDA i17.0114.11
Risk & Other Metrics
Beta i0.370.26
Book Value per Share (MRQ) i₹127.00₹214.12

Financial Statements Comparison: Advanced Enzyme vs Rossari Biotech

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ADVENZYMESROSSARI
Revenue/Sales i₹1.86B₹5.44B
Cost of Goods Sold i₹500.49M₹3.71B
Gross Profit i₹1.36B₹1.72B
Research & Development iN/AN/A
Operating Income (EBIT) i₹468.14M₹501.06M
EBITDA i₹652.82M₹695.76M
Pre-Tax Income i₹549.00M₹460.99M
Income Tax i₹144.60M₹125.03M
Net Income (Profit) i₹404.40M₹335.96M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ADVENZYMESROSSARI
Cash & Equivalents i₹942.25M₹442.02M
Total Current Assets i₹8.80B₹10.42B
Total Current Liabilities i₹967.55M₹5.37B
Long-Term Debt i₹209.17M₹1.22B
Total Shareholders Equity i₹14.69B₹11.85B
Retained Earnings i₹11.53B₹6.97B
Property, Plant & Equipment i₹2.93B₹0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ADVENZYMESROSSARI
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricADVENZYMESROSSARI
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i172,31477,738
Average Daily Volume (90 Day) i872,28255,618
Shares Outstanding i111.88M55.36M
Float Shares i29.32M16.62M
% Held by Insiders i0.56%0.55%
% Held by Institutions i0.21%0.19%

Dividend Analysis & Yield Comparison: Advanced Enzyme vs Rossari Biotech

MetricADVENZYMESROSSARI
Last 12-Month Dividend i₹5.20₹43.78
Last 12-Month Dividend Yield i1.56%6.54%
3-Year Avg Annual Dividend i₹5.43₹14.93
3-Year Avg Dividend Yield i0.75%1.66%
3-Year Total Dividends i₹16.30₹44.78
Ex-Dividend DateJul 23, 2025Jun 20, 2025